Mersana Therapeutics, Inc. Total Long-Term Debt
Mersana Therapeutics, Inc. had Total Long-Term Debt of $20.10 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2024-05-09
- 2024-03-31: Long-term Debt $20.10M.
- 2023-12-31: Long-term Debt $23.15M.
- 2023-09-30: Long-term Debt $25.16M.
- 2023-06-30: Long-term Debt $25.08M.
| Period end | Long-term Debt |
|---|---|
| 2024-03-31 | $20.10M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $23.15M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $25.16M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $25.08M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $25.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $24.93M 10-Q · filed 2023-11-07 |
| 2022-09-30 | $24.85M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $24.78M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $24.70M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $24.63M 10-Q · filed 2022-11-07 |
| 2021-09-30 | $5.08M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.87M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $5.01M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $4.98M 10-Q · filed 2021-11-09 |
| 2020-09-30 | $4.94M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $4.80M 10-Q · filed 2019-08-08 |